---
layout: minimal-medicine
nav_exclude: true
title: Trabectedin
---

# Trabectedin

**Generic Name:** Trabectedin

**Usage:** Trabectedin is an antineoplastic (anticancer) medication used to treat certain types of rare cancers.  Specifically, it's approved for:

* **Soft tissue sarcoma:**  Advanced soft tissue sarcoma (liposarcoma and leiomyosarcoma) in adults who have already received at least one prior chemotherapy regimen.
* **Ovarian cancer:**  Relapsed or refractory (resistant to treatment) ovarian cancer in adults after at least three prior chemotherapy regimens, including platinum-based chemotherapy.


**Side Effects:**  Trabectedin can cause a wide range of side effects, some common and others rare but serious.  These can include:

* **Common side effects:**  Fatigue, nausea, vomiting, diarrhea, constipation, loss of appetite, headache, neutropenia (low white blood cell count), thrombocytopenia (low platelet count), anemia (low red blood cell count), increased liver enzymes (liver damage indicators).
* **Serious side effects:**  Severe neutropenia (increasing infection risk), severe thrombocytopenia (increased bleeding risk), severe anemia, allergic reactions (including anaphylaxis), heart problems (arrhythmias), liver failure, kidney damage, peripheral neuropathy (nerve damage in the hands and feet),  and muscle weakness.  These serious side effects require immediate medical attention.


**How it Works:** Trabectedin is a synthetic analogue of ecteinascidin 743, a natural substance extracted from a marine tunicate. Its exact mechanism of action is not fully understood, but it is believed to work by:

* **Intercalating into DNA:** Trabectedin binds to the minor groove of DNA, interfering with its structure and function.
* **Inhibiting transcription and replication:** This binding disrupts DNA replication and transcription (the process of making RNA from DNA), ultimately leading to cell death in cancer cells.
* **Modulating the immune system:** Some studies suggest trabectedin may also have immunomodulatory effects, meaning it can alter the body's immune response to cancer.


**FAQs:**

* **Q: How is trabectedin administered?** A: Trabectedin is administered intravenously (IV) over a period of several hours.  The specific dosage and infusion schedule are determined by a physician based on the patient's individual condition and response to treatment.
* **Q: What are the precautions I should take while on trabectedin?** A:  Close monitoring of blood counts (complete blood count or CBC), liver and kidney function is necessary. Patients should report any unusual symptoms to their doctor immediately.  Avoid alcohol consumption during treatment.
* **Q: Are there any drug interactions with trabectedin?** A: Yes, several drug interactions are possible.  It's crucial to inform your doctor of all medications, including over-the-counter drugs and supplements, you are taking.  Strong CYP3A4 inhibitors (like ketoconazole) can increase trabectedin levels, potentially increasing the risk of side effects.
* **Q: What are the long-term effects of trabectedin?** A: Long-term effects can include peripheral neuropathy, which may persist after treatment completion.  Regular follow-up appointments are necessary to monitor for any long-term side effects.
* **Q: Is trabectedin a cure for cancer?** A: No, trabectedin is not a cure for cancer.  It's a chemotherapy drug used to treat advanced or refractory cancers, aiming to shrink tumors and/or prolong survival.  The effectiveness varies depending on the individual and the type of cancer.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice. Always consult with a healthcare professional before starting any new treatment, including trabectedin.  They can provide personalized advice based on your specific health situation.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.